“Highest user rated on Google Play and App Store for TENS connected applications in France.
The neurostimulator and the mobile application are regulated health products which carry the CE mark (2797).
actiTENS has been cleared by the FDA in December 2020 but it is not yet marketed or sold in the United States.
Please refer to our 510(K) Application N°K202159 for any additional information or contact us at contact@subli-med.com
TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION
In Europe, about one adult out of five suffers from chronic pain. Chronic pain is defined as a pain that persists for 3 months beyond a reasonable healing time.
Beyond medical painkiller treatments, there are alternative and complementary therapeutic solutions, including Transcutaneous Electrical Nerve Stimulation, more commonly called TENS.
actiTENS is a compact and connected new-generation TENS, the objective of which is to allow chronic pain sufferers to live and move around with their nerve stimulator.
actiTENS is a discreet, ergonomic and connected new-generation transcutaneous electrical nerve stimulator (TENS). actiTENS was developed with the help of many expert pain centres in France and groups of patients who agreed to test the equipment’s ergonomy and its smartphone app.
actiTENS has the CE marking.
The actiTENS system is an assembly of medical devices. Please refer to the instructions for use for more information.
The neurostimulator and the mobile application are regulated health products which carry the CE mark (2797), manufactured by SUBLIMED 813 959 012 RCS Grenoble. Kit assembled by SUBLIMED (within the meaning of Article 22 of Regulation 2017/745).
